519 related articles for article (PubMed ID: 24880489)
21. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039
[TBL] [Abstract][Full Text] [Related]
23. Hydrazinyl arylthiazole based pyridine scaffolds: Synthesis, structural characterization, in vitro α-glucosidase inhibitory activity, and in silico studies.
Ali F; Khan KM; Salar U; Taha M; Ismail NH; Wadood A; Riaz M; Perveen S
Eur J Med Chem; 2017 Sep; 138():255-272. PubMed ID: 28672278
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 2-indolcarbohydrazones as potent α-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions.
Taha M; Ismail NH; Javaid K; Imran S; Anouar el H; Wadood A; Atia-Tul-Wahab ; Ali M; Khan KM; Saad SM; Rahim F; Choudhary MI
Bioorg Chem; 2015 Dec; 63():24-35. PubMed ID: 26398141
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of α-glucosidase inhibiting potentials with docking calculations of synthesized arylidene-pyrazolones.
Chaudhry F; Naureen S; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Jahan B; Hyder Khan M; Iqbal F; Ali Munawar M; Ain Khan M
Bioorg Chem; 2018 Apr; 77():507-514. PubMed ID: 29454828
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and α-glucosidase inhibition activity of dihydroxy pyrrolidines.
Kasturi S; Surarapu S; Uppalanchi S; Anireddy JS; Dwivedi S; Anantaraju HS; Perumal Y; Sigalapalli DK; Babu BN; Ethiraj KS
Bioorg Med Chem Lett; 2017 Jun; 27(12):2818-2823. PubMed ID: 28495082
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
[TBL] [Abstract][Full Text] [Related]
29. Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors.
Suresh L; Onkara P; Kumar PS; Pydisetty Y; Chandramouli GV
Bioorg Med Chem Lett; 2016 Aug; 26(16):4007-14. PubMed ID: 27406797
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, in vitro evaluation and molecular docking studies of novel amide linked triazolyl glycoconjugates as new inhibitors of α-glucosidase.
Gupta SJ; Dutta S; Gajbhiye RL; Jaisankar P; Sen AK
Bioorg Chem; 2017 Jun; 72():11-20. PubMed ID: 28346871
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
32. A concise synthesis of N-substituted fagomine derivatives and the systematic exploration of their α-glycosidase inhibition.
Jiang FX; Liu QZ; Zhao D; Luo CT; Guo CP; Ye WC; Luo C; Chen H
Eur J Med Chem; 2014 Apr; 77():211-22. PubMed ID: 24642564
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
[TBL] [Abstract][Full Text] [Related]
34. Organocatalyzed solvent free an efficient novel synthesis of 2,4,5-trisubstituted imidazoles for α-glucosidase inhibition to treat diabetes.
Yar M; Bajda M; Shahzad S; Ullah N; Gilani MA; Ashraf M; Rauf A; Shaukat A
Bioorg Chem; 2015 Feb; 58():65-71. PubMed ID: 25462626
[TBL] [Abstract][Full Text] [Related]
35. Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase.
Wei M; Chai WM; Wang R; Yang Q; Deng Z; Peng Y
Bioorg Med Chem; 2017 Feb; 25(4):1303-1308. PubMed ID: 28110817
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, molecular docking studies of hybrid benzimidazole as α-glucosidase inhibitor.
Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F
Bioorg Chem; 2017 Feb; 70():184-191. PubMed ID: 28043716
[TBL] [Abstract][Full Text] [Related]
37. α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study.
Proença C; Freitas M; Ribeiro D; Oliveira EFT; Sousa JLC; Tomé SM; Ramos MJ; Silva AMS; Fernandes PA; Fernandes E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1216-1228. PubMed ID: 28933564
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM
Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors.
Zhen J; Dai Y; Villani T; Giurleo D; Simon JE; Wu Q
Bioorg Med Chem; 2017 Oct; 25(20):5355-5364. PubMed ID: 28797772
[TBL] [Abstract][Full Text] [Related]
40. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
